Exited position

David Tepper’s Hca Healthcare Inc (HCA) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Appaloosa LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2016Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares3.17MHighest verified quarter-end share count
Quarters reported21Verified quarters with shares above zero
What happened?

Appaloosa LP first reported Hca Healthcare Inc in Q1 2016. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Appaloosa LP sold the entire position in Q1 2024, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2024
Sold the entire position−117.20K shares · No shares reported at quarter-end
Q4 2023
New position+117.20K shares · 117.20K shares reported
Filing context

Quarter-end price $270.68 · Estimated holding basis $270.68

Q2 2023
Sold the entire position−142.50K shares · No shares reported at quarter-end
Q1 2023
Sold 21.9% of the position−40.00K shares · 142.50K shares remained
Filing context

Quarter-end price $263.68 · Estimated holding basis $210.41

Q4 2022
Bought 143.3% more+107.50K shares · 182.50K shares reported after the change
Filing context

Quarter-end price $239.96 · Estimated holding basis $210.41

Q2 2022
New position+75.00K shares · 75.00K shares reported
Filing context

Quarter-end price $168.07 · Estimated holding basis $168.07

1 unchanged quarter is collapsed by default.

Portfolio importance

How important was Hca Healthcare Inc in Appaloosa LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.6%Q4 2023
Last reported rank#26of 39 reported positions
Peak portfolio weight5.0%Q1 2016
Best historical rank#6Q1 2016
At peak importanceQ1 2016
HCA
5.0%
Largest holding
10.5%
Cross-investor discovery

Who else owns Hca Healthcare Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Ray DalioBridgewater Associates, LP
HCA0.3% of reported portfolio
Joel GreenblattGotham Asset Management
HCA0.1% of reported portfolio
Explore Hca Healthcare Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$426.942026-09-11

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Appaloosa LP’s Form 13F disclosures—not David Tepper’s personal brokerage account. Form 13F reports quarter-end U.S.-listed positions and certain options, but it does not reveal exact trade dates, execution prices, short positions or the purpose of an option position.